New Zealand markets open in 6 hours 24 minutes

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4350+0.1650 (+12.99%)
As of 11:36AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate-0.39-0.39-1.68-0.88
Low estimate-0.43-0.41-1.69-1.19
High estimate-0.37-0.37-1.66-0.67
Year ago EPS-0.56-0.48-2.27-1.68
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate37.74M40.74M148.4M193.79M
Low estimate34.71M36.91M138.01M151.6M
High estimate42M45M161M246M
Year ago salesN/A35.97M148.76M148.4M
Sales growth (year/est)N/A13.30%-0.20%30.60%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-0.48-0.57-0.43-0.41
Actual EPS-0.56-0.48-0.44-0.5
Difference-0.080.09-0.01-0.09
Surprise %-16.70%15.80%-2.30%-22.00%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.39-0.39-1.68-0.88
7 days ago-0.41-0.38-1.66-0.85
30 days ago-0.41-0.38-1.66-0.83
60 days ago-0.41-0.38-1.66-0.83
90 days ago-0.41-0.38-1.66-0.83
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 days1N/AN/AN/A
Up last 30 days1N/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A111
Growth estimatesCLVSIndustrySector(s)S&P 500
Current qtr.30.40%N/AN/AN/A
Next qtr.18.70%N/AN/AN/A
Current year26.00%N/AN/AN/A
Next year47.60%N/AN/AN/A
Next 5 years (per annum)79.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A